Grail Stock Plunge Sparks Contrarian Investment Debate
Grail shares fell sharply after a failed clinical trial, but some analysts see a 30% upside. The biotech firm’s revenue is growing, yet FDA approval remains elusive.
Read MoreGrail shares fell sharply after a failed clinical trial, but some analysts see a 30% upside. The biotech firm’s revenue is growing, yet FDA approval remains elusive.
Read MoreOn Holding AG co-founders David Allemann, Casper Coppetti, and Olivier Bernhard collectively bought 180,000 Class A shares for $6.6 million, signaling long-term confidence amid market pressures.
Read MoreRipple achieves $50B valuation and major partnerships, but XRP token falls 60% from peak. RLUSD stablecoin offers alternative amid volatility.
Read MoreInfluencer Jake Shane says he is not a journalist after facing backlash over a Therapuss interview with Kacey Musgraves, where he questioned a lyric about time zones.
Read MoreJenny Slatten, 68, of 90 Day Fiancé, reveals her ALS diagnosis after a year of symptoms. Her father died from the same disease. She and husband Sumit Singh seek treatments.
Read MoreA personal reflection on what makes a home, from a cat’s loyalty to relocating entire houses, exploring the deep ties between family, memory, and place.
Read MoreLong-term US Treasury yields surged to multi-decade highs on Monday, with the 30-year bond reaching 5.15% and the 10-year note climbing to 4.63%, driven by inflation fears and debt concerns.
Read MoreNetflix, once a FAANG star, now lags behind Magnificent Seven. With steady revenue growth, AI investments, and a 28 P/E ratio, is it a buy?
Read MoreThe Trump administration extended the US waiver on Russian crude for 30 days, providing relief to Indian refiners amid Gulf disruptions. China’s large stockpiles buffer impact, while India faces critical lows.
Read MoreKyle Cooke responds to fans accusing him and Amanda Batula of faking their split for ratings, defending the reality of their marriage and the show’s unscripted nature.
Read More